News Hub | News Direct

THE INDO-AMERICAN ARTS COUNCIL ANNOUNCES ANNUAL WEEKLONG LITERARY FESTIVAL

IAAC

- In Its 8th Year, the IAAC Literary Festival offers an intimate interaction with the leading minds and works of authors and poets writing about the Indian experience - The Indo-American Arts Council ( IAAC ), the organization dedicated to celebrating and showcasing the arts in North America, announced today the lineup for its eighth annual Literary Festival on November 7-13, 2022, in New York. Notable speakers, making in-person appearances at the Caelum Gallery (526 W 26th St.) in NY’s renowned Chelsea neighborhood, include Padma Shri, Barkha Dutt, Priya Kumari and Raza Mir. In continuation of its honored tradition, IAAC will also host a live Poetry Panel headlining Arundhathi Subramaniam and moderated by poetry curator, Dr. Ravi Shankar. Prior to the in-person weekend events, there will be a series of virtual events hosted on Facebook and YouTube each evening starting November 7-11 at 6:30 p.m. ET, which will feature ten writers including Nobel Peace Prize winner Kailash Satyarthi; London-based restaurateur and Netflix’s “Chef’s Table” star, Asma Khan with Michelin Chef Vikas Khanna - author of the world’s first “phygital” (physical and digital) cookbook; plus, actress, dancer and choreographer, Rukmini Vijayakumar. This series also includes a dedicated Children’s Literary Panel on Tuesday, November 8, 2022 which will showcase readings of “When Blackbirds Fly” by Hannah Lalhlanpuii and “Jamlo Walks” by Samina Mishra. "IAAC's Literary Festival showcases writers who bring stories of the Indian experience and ethos to the world. Even as they set new standards of literary excellence, they excite our imagination and shape humanity's future through their thought leadership. The festival attendees will become part of extraordinary conversations. Supporting the festival will be a stellar group of moderators who themselves are literary luminaries. As always there will be a focus on first time regional translations, children's literature and poetry," said Rakesh Kaul, Vice Chairman, IAAC. IAAC’s literary festival will be an intense two-day immersive experience featuring thought-provoking conversations, readings and discussions of stories told by courageous authors. Each authors' skill and expertise cover a wide range of civilizational and cultural topics including archeology, design, dance, history, compassion, wonder and the culinary arts. A panel of four poets will showcase powerful word-play that will make imaginations soar and speak directly to hearts, young and old. Refreshments, breakfast and lunch will be served, wine and cheese will accompany the poetry session. The festival wraps on a high note with the Annual Gala on November 13th. “At IAAC, we pride ourselves on our ability to seek out and find foundational storytellers who are not only noteworthy for their skill with language but whose seminal works also weave remarkable narratives that shape the world around them. This year is no exception; I have had the privilege to work with a dedicated team of literature lovers whose hard work and energy made this festival possible,” said Preethi Urs, Literary Festival Director, IAAC. A full list of writers and featured works below. For the full schedule with dates, times and moderators, please visit IAAC.us. Virtual Events (November 7-11): Kailash Satyarthi's greater body of work Ammu: Indian Home Cooking to Nourish your Soul (Interlink Books, May 2022) by Asma Khan Sacred Foods of India in NFT format (Akshaya, June 2022) by Vikas Khanna His Holiness the Dalai Lama in 100 Anecdotes (India Penguin, December 2022) by Arthy Muthanna Singh and Mamta Nainy The Dalai Lama: Leadership and the Power of Compassion (Interlink Books, November 2022) by Ginger Chih which includes a forward by His Holiness the Fourteenth Dalai Lama Finding Shiva: An Inner Journey of the Performative Experience (INDIC, 2021) by Rukmini Vijayakumar Virtual Children’s Panel: When Blackbirds Fly (Duckbill, February 2022) by Hannah Lalhlanpuii Jamlo Walks (India Puffin, September 2021) by Samina Mishra Somnath Hore: Wounds (Art1st, August 2021) conceptualized by Ritu Khoda, written by Likla Lall and featuring illustrator, Kripa (additionally, featuring in-person on November 13) In-Person Events (November 12-13): The Way of the Goddess: Daily Rituals to Awaken Your Inner Warrior and Discover Your True Self (TarcherPerigee, September 2022) by Ananta Ripa Ajmera Tata's Leadership Experiment: The Story of the Tata Administrative Service (HarperBusiness, August 2022) by Bharat Wakhlu, Mukund Rajan, Sonu Bhasin TO HELL AND BACK: Humans of COVID (Juggernaut, February 2022) by Barkha Dutt The Greatest Telugu Stories Ever Told (Rupa, March 2022) translated by Tamraparni Dasu and Dasu Krishnamoorty A Country Called Childhood: A Memoir (Aleph Book Company, July 2022) by Deepti Naval [Block] Chain Reaction - The Future of How We Live and Work (Soul Excellence Publishing, January 2022) by Elizebeth Varghese Tomb of Sand: A Novel by Geetanjali Shree (Tilted Axis Press, August 2021), translated by Daisy Rockwell Shehnai Virtuoso and Other Stories by Dhumketu (Deep Vellum Publishing, July 2022) translated by Jenny Bhatt Rajaraja Chola: King of Kings (Aleph Book Company, November 2022) by Kamini Dandapani Dava Shastri's Last Day (Grand Central Publishing, November 2021) by Kirthana Ramisetti A Matter of Trust (HarperCollins India, July 2021) by Meenakshi Ahamed The View from the Very Best House in Town (Walker Books US, February 2022) by Meera Trehan The Soul Catcher (Bodes Well Publishing, September 2021) by Monica Bhide Mirror Made of Rain (The Unnamed Press, May 2022) by Naheed Phiroze Patel The Candid Life of Meena Dave (Lake Union Publishing, June 2022) by Namrata Patel People of the Indus (India Penguin, November 2022) by Nikhil Gulati Leaf Talks Peace - Buddha's Message of Harmony (Eternal Tree Books, May 2022) by Priya Kumari Talent: The Market Cap Multiplier (Ideapress Publishing, January 2022) by Ram Charan and Anish Batlaw Murder at the Mushaira: A Novel (Rupa Publications India, January 2021) by Raza Mir Smashing the Patriarchy: A Guide for the 21st-Century Indian Woman (Rupa, November, 2021) by Sindhu Rajasekaran KALA - Essays on Contemporary Design Aesthetics (Times Group Books, 2020) edited by Padma Shri Sunita Kohli Somnath Hore: Wounds (Art1st, August 2021) conceptualized by Ritu Khoda, written by Likla Lall and featuring illustrator, Kripa Notable International Poets: Love Without a Story (Westland, April 2019) by Arundhathi Subramaniam My Body Lives Like a Threat (Flowersong Press, January 2022) by Megha Sood Time Regime (Gaudy Boy, March 2022) by Jhani Randhawa Singing in the Dark (Vintage Books, October 2020) edited by Nishi Chawla and K Satchidanandan Attendance Details: For a complete calendar of events between on November 7-13, 2022, visit https://iaac.us/iaac-literary-festival-2022/ RSVP for both in-person and online events at: https://www.eventbrite.com/e/iaac-literary-festival-2022-tickets-446199724387 Social Media for IAAC: Facebook: https://www.facebook.com/iaac.us YouTube: https://www.youtube.com/channel/UC7XldGWApKYy-IvQPapxFJg Twitter: https://twitter.com/IAArtsCouncil Instagram: https://www.instagram.com/iaacny Hashtag: #IAACLitFest For a full press kit including photos and posters: https://drive.google.com/drive/folders/1DtbCXBSbA25yTQmf7vfMEWcdWFOGszA-?usp=sharing For IAAC Suman Gollamudi, Executive Director, Indo-American Arts Council suman.gn@iaac.us About Indo-American Arts Council (IAAC): The IAAC supports all the artistic disciplines in classical, fusion, folk and innovative forms influenced by the arts of India. We work cooperatively with colleagues around the U.S. to broaden our collective audiences and to create a network for shared information, resources and funding. Our focus is to help artists and art organizations in North America as well as to facilitate artists from India to exhibit, perform and produce their work here. The IAAC is a 501(c)(3) tax-exempt organization. All donations are tax-deductible to the fullest extent allowable by law. For information, please visit www.iaac.us. For a full press kit including photos and posters: https://drive.google.com/drive/folders/1DtbCXBSbA25yTQmf7vfMEWcdWFOGszA-?usp=sharing Contact Details Indo-American Arts Council Suman Gollamudi, Executive Director suman.gn@iaac.us

November 02, 2022 04:57 PM Eastern Daylight Time

Image

Intus Care Closes $14.1M Series A to Advance Adoption of First-of-its-kind Predictive Analytics Platform for Geriatric Populations

Intus Care

Intus Care, developer of an innovative predictive analytics platform aimed at improving geriatric care outcomes, today announced the close of its Series A, securing over $14M led by Deerfield Management. Other undisclosed investors contributed to the raise through additional cash investments and conversion of existing debt. Founded in 2019 by Brown University undergraduate students, Intus Care’s mission is to empower geriatric care providers through data to deliver more effective patient management and treatment for dual-eligible seniors -- some of the most socially vulnerable and clinically complex people in the U.S. “We are extremely impressed both by the impact that Intus Care’s technology is poised to have on patient outcomes, and by the passion and dedication of its team,” said Dr. Julian Harris, operating partner at Deerfield Management. “We are proud to invest in a company we believe will be vital to revolutionizing geriatric care.” Intus Care’s technology platform enables care providers to mitigate preventable high-utilization events, track quality interventions, and equip healthcare management teams with vital actionable insights to make informed decisions for senior patients to improve their health outcomes. Its digital healthcare platform integrates with electronic health records, claims, and accounting software to highlight clinical risks in patients and display organizational data. This offers a holistic view of each patient in an organization, allowing healthcare teams to better plan, manage, and provide quality care to the most vulnerable senior populations in our communities. “To have an investor as esteemed in the healthcare industry as Deerfield Management recognize our value enough to lead our Series A is truly humbling,” said Robbie Felton, CEO and co-founder of Intus Care. “As a child, I watched my mother – then a geriatric social worker in Detroit – navigate the obstacles of caring for a disadvantaged population. Today, it makes me extremely proud to be providing caregivers with predictive analytics technology that will allow them to make more informed decisions for their patients that may lead to better outcomes.” Intus Care currently works with over 25 PACE Programs in 13 states who are utilizing its first-of-its-kind predictive analytics platform and entered a Letter of Understanding with the National PACE Association to pursue a strategic partnership. “Robbie and I are proud to be impacting the elder care space, and also hope to inspire other young entrepreneurs of color,” said Evan Jackson, COO and co-founder of Intus Care. “We are very appreciative to have earned the support of Deerfield Management and our other investors and are excited by the possibilities that their investment will enable us to actualize.” The latest investment round will position the company to maximize greater technological opportunities through data, honing product strategy that will support a major scale-up of their current service offerings. They also plan to grow their human capital by attracting, hiring, and retaining strong talent committed to their mission. About Intus Care Intus Care synthesizes data to improve care and reduce hospitalizations for some of the most socially vulnerable and clinically complex patients in today’s healthcare system – senior citizens. The company has created a unique data-driven predictive analytics platform designed for organizations such as PACE programs, nursing homes, long-term care facilities, and home care agencies. It easily integrates with existing electronic health records, claims, and financial software to automatically extract and analyze data. By highlighting participant risk and care-focused information, the Intus Care software empowers clinicians, nurses, and other care providers by informing decisions that improve outcomes and reduce unnecessary costs. Learn more at intuscare.com. Contact Details SVM Public Relations Jordan Bouclin +1 401-490-9700 intuscare@svmpr.com Company Website https://www.intuscare.com/

November 02, 2022 10:40 AM Eastern Daylight Time

News Release

Livewire’s Estrella Weedery Is The World’s First Estate-Grown Weedery — A Sustainable Cannabis Farm and Destination Focused On Premium Organic-Style Specialty Cannabis Products

LiveWire Ergogenics, Inc.

Livewire Ergogenics Inc. trading at the OTC Marketplace under (OTCMKTS: LVVV) is a company focused on acquiring, managing, leasing, and licensing special-purpose real estate properties and operations conducive to producing high-quality, handcrafted, and organically grown specialty cannabis products for medical and recreational adult-use in California. The company’s main operations are in Paso Robles, California, including the recently acquired Estrella Ranch nestled among hundreds of world-renowned vineyards and Makana Ola Farms In Humboldt, California. The company says the Estrella Ranch property is the home to the world’s first “Estate Grown Weedery”, following the well-established vineyard business model, eventually developing it into a cannabis tourist destination in California. Already an active cannabis-producing property, the company is turning Estrella Ranch into multiple revenue-stream properties while preserving its natural splendor and prioritizing environmentally conscious cultivation and business practices every step of the way, leaving behind the smallest possible carbon footprint possible. Handcrafted Organic Cannabis Specialty Products May Help Keep Profit Margins High With its initial pilot harvest completed last October, Livewire took the first step toward establishing the Estrella Weedery brand. The harvest was carried out by Livewire’s affiliate company, Estrella River Farms which operates the cultivation on the Estrella property. ERF is using state-of-the-art techniques to develop a sustainable, organic farm for growing a variety of premium cannabis specialty products. The tractorless cultivation process uses less water, less fertilizer, and no toxic pesticides. The result is high-potency, premium cannabis that takes considerably less water than comparable cultivation processes to produce. To stay competitive with bigger California producers like Lowell Farms Inc. (OTCQX: LOWLF) or Glass House Brands (OTCQX: GLASF), LiveWire’s Estrella River Farms is focused on cultivating organic-style specialty products with higher profit margins. By focusing on quality instead of quantity (grow by the pound - sell by the gram), the company hopes to avoid the high cost and low return of mass-produced cannabis. As the trend toward widespread legalization continues with 52% of Americans living in areas with marijuana legalized in some form, the cost of cannabis has dropped in the United States, sinking to its lowest price in over three years in June. In Canada, nationwide legalization was followed by a 13% drop in price in the first year. Since then, retail prices across categories have continued to dip as more producers entered the space still having to compete with larger illicit sales for market share. While that drop will likely level out, companies with tight margins are going to have a hard time staying competitive without differentiating their products in distinctive ways. For Livewire, that differentiation comes from quality specialty products, environmentally conscious production, and operating with significantly lower production costs to keep profit margins high. In addition to its business-to-business sales, the company intends to get its premium Estrella Weedery branded product onto every dispensary shelf in California — either as a specialty product under its own brand or as a licensed private-label product under third-party brands. Livewire has also partnered with home-delivery services Kushagram and Green Eagle to deliver its cannabis products directly to consumers. Applying The Tried And True Vineyard Model To Cannabis Cultivation Is Expected Generate Additional Revenue The ultimate vision at Estrella Ranch is simple: Sell its high-quality specialty products B to B and Direct to Consumers. Ultimately, create an idyllic wellness retreat complete with scenic vistas and currently over 130,000 square feet of sustainably cultivated cannabis, multiple offices, secure storage buildings, and large living quarters. When the project is finished, Livewire hopes to have roughly six (6) acres of outdoor growing area, and 22,000 square feet of indoor cultivation,— all while carefully preserving the natural, open landscape of rolling hills and well-watered ranchland. Livewire’s Plan Is to Generate Multiple Revenue Streams From One Low-Cost Operation Livewire chose the Estrella Ranch location, in part, for the ideal micro-climate that makes organic, sun-grown outdoor cannabis cultivation possible. In less ideal climates, cultivators typically opt for indoor production to increase yield and compensate for poor weather or lack of sun. But growing indoors means spending more on energy, facility maintenance, and other expenses that bring median average production costs up to $472 per pound. At Estrella, Livewire says production costs average under $100 per pound for its organic-style outdoor cultivation. The company states that the lower production cost paired with its plan to eventually generate revenue from the property via a first-of-its-kind cannabis wellness retreat and both direct-to-consumer and business-to-business sales of the cannabis it grows creates the potential for a wide margin and substantial growth potential. Livewire Ergogenics Inc. focuses on acquiring, managing, and licensing well-qualified cannabis real estate locations to establish fully compliant and permitted facilities to produce cannabis-based products and establish relationships for the statewide distribution of these products in California. This includes developing and licensing high-quality organic cannabinoid-based products and services and creating the high-quality "Estrella Grown Weedery™" brand via its subsidiary/affiliate companies Estrella Ranch Partners, Estrella River Farms, Makana Ola, and CaliCruz Farms. LiveWire Ergogenics does not produce, sell, or distribute products that violate the United States Controlled Substances Act. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Tristan Cavato ir@livewireergogenics.com

November 02, 2022 08:15 AM Eastern Daylight Time

Valant Unveils MYIO, a First-of-its-Kind Patient Portal Mobile App for Behavioral Healthcare

Valant

Valant, a leading EHR for behavioral healthcare practices, today launched MYIO, the first all-in-one behavioral health-specific patient engagement mobile app. MYIO, which is short for My Improved Outcomes, offers a secure solution intended to improve both patient and practice outcomes. It enables practices to boost productivity and streamline operations while increasing patient engagement. With MYIO, patients can join telehealth sessions, sign intake forms, complete assessments, securely message their behavioral health provider, view and request appointments, update payment information, and make online payments. This alleviates the burden often placed on administrative staff and allows them to handle patient questions and requests that do not require their provider's attention. Additionally, MYIO alleviates manual tasks once left to providers, giving them the opportunity to focus on patient care. MYIO helps behavioral healthcare practices bypass the manual entry of patient data into multiple systems, thereby improving operational efficiencies. With the app, new patients can easily onboard by entering demographic data and submitting credit card and insurance information, signing clinical intake forms, requesting appointments, paying balances, and more. “Mental health requires constant communication and engagement to keep patients motivated to continue their care. Our vision with MYIO is to give providers a means to keep that engagement going, long after appointments are complete,” said Valant’s Chief Executive Officer, Ram Krishnan. “We are pleased to offer patients a cohesive, supportive experience and providers the technology to help make high-quality behavioral healthcare available to everyone while improving outcomes. Practices with outpatient behavioral health clients will benefit by having this secure central hub to stay connected and also have access to health data.” While using the app, patients can communicate with their behavioral healthcare provider or office staff to schedule appointments, request prescription refills, and register for additional services from their portal account using the integrated secure messaging feature. Willamette Health & Wellness, a behavioral healthcare practice in Portland, OR, is an early adopter of the MYIO app. Prior to working with Valant, Williamette’s billing department spent hours manually sending patients billing statements and asking them to pay bills through a separate system. “Our previous billing process was very labor-intensive for the practice and unnecessarily complex for patients,” said Willamette Health & Wellness Billing Specialist Shea Musick. “We used to have an entire manual workflow dedicated to sending out statements, replying to questions, and directing patients to submit payments on the practice website via a third-party portal. Valant’s integrated patient portal app, MYIO, has completely streamlined the process, saving our office hours of administrative work each day.” MYIO offers integrated secure messaging and a streamlined way for behavioral healthcare practices to: Securely communicate with patients outside of appointments; Give patients access to their behavioral health information and upcoming appointments; Automatically collect and update patient information; Send outcome measures for patients to complete prior to and in between visits; Receive patient payments and signed intake or consent forms; Host virtual visits with patients, with the option to automatically collect payment prior to the session; and Offer behavioral health resources for ongoing patient education. The release of MYIO coincides with significant improvements to Valant’s browser-based patient portal experience and secure messaging feature. To learn more, visit valant.io. About Valant Valant is a cloud-based integrated EHR software suite that supports the administrative operations of behavioral healthcare practitioners, agencies, and clinicians. The software offers features including individual and group appointment scheduling, treatment planning, medication management, patient engagement, billing, and reporting. Valant collects and organizes data from patients and providers, documents them using guided protocols, and stores them securely. Actionable insights and reports are also generated based on the data collected. Valant is built for large outpatient practices and solo providers including psychiatrists, nurse practitioners, psychologists, therapists, and counselors. To date, thousands of organizations across all 50 states utilize Valant to decrease costs and manage ever-changing compliance requirements. Learn more at valant.io. Contact Details Jennifer Mirabile Trust Relations valant@trustrelations.agency

November 02, 2022 08:00 AM Eastern Daylight Time

Video

PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE

ProText Mobility, Inc.

Protext Mobility, Inc. (OTC PINK: TXTM) and RSAMMDA LLC (Delaware) (“RSAMMDA.LLC”) are pleased to provide the following shareholder update and announce an initial order for 2.33 million pounds of Genus Cannabis Sativa under a supply agreement. Dr. Ahmed Jamaloodeen (Dr.J), Protext Chairman commented, “This is a terrific milestone and demonstrates years of hard work and relentless pursuit of educating the masses and government collaboration. The initial order calls for the delivery of 2.33 million pounds of cannabis, arguably the largest single cannabis flower and biomass order in history to date post legalization. The specific strain we are growing for this order is Charlottes Angel for high percentage CBD flower and biomass. Everything we do is under South Africa federally issued permits, and license to import, export, grow hemp and cannabis from seed to sale, R & D, as well as develop and distribute our own brand of finished products. “Our proprietary, branded CBD product line and online marketplace is anticipated to launch shortly. Due to our early pioneering of hemp and cannabis as a massive community uplift opportunity in South Africa, we were approved as the first government sponsored pilot project that would enable proof of concept to other farms as a blueprint of this business model. This early blueprint is now a proven business model for South African farmers, and we are now at the forefront of SA becoming a recognized global leader in hemp and cannabis production. To further these efforts, last week I attended the AFASA AGM conference and gave a presentation to 1000’s of farmers who are now part of the Cannabis Commodity Cluster Formation, which I’ve been appointed as National Cannabis Commodity Chairman – The first in history.” (link to Dr.J Cannabis Expo 2022 presentation discussing SA community uplift and cannabis: youtube.com/DR.J ) Dylon Du Plooy, Protext CEO, commented, “The hemp renaissance is well underway, with renewed interest from global industrial companies to find cheaper and greener resources that can be used to produce 1000’s of end product. America is decades behind the sustainable materials revolution. That represents a big opportunity for us to unlock the potential of industrial hemp in the world’s strongest economy, with the lowest cost product available globally. For South Africa, the opportunity is to take a global role in what we believe is the beginning of an industrial hemp renaissance. We can not only produce product at the lowest cost basis on a global basis, but we can monetize the farm with 3 annual grows, making our hemp, biomass, and cannabis much sought after from customers around the world. In fact, this substantial off take agreement for an initial 2.3 m illion pounds is being delivered to a US customer. Why? Not only for the quality of the product, but our cost basis is so competitive we can deliver product that includes freight shipping cost to US customers, that is lower than they can get anywhere in North America.” #TXTMTribe #TXTMTribeRaok #TXTMRaok. Dr. J continued, “As we have previously discussed, we believe there is significant value in the human capital derived from our knowledge, Government and other relationships, compliance, resources, facilities, biomass, and infrastructure that is invaluable. The Permits we are in possession of allow for Genus Cannabis Sativa import, export, grow & cultivation, research, testing, and end product development for global distribution, all of which are anticipated to be utilized by Protext with the end goal to commercialize the live plant extraction technology and bring superior end products to the global market. Having technology that’s been tested and proven to increased bioavailability by 10-15x is significant and puts us miles ahead of all competitors. Additional testing is anticipated to be conducted with cannabis being grown on the farm right now. The testing will focus on maximizing yield as well as testing various strains of Genus Cannabis Sativa. We will also begin conducting the R&D using the New Age Extraction Technology for other Indigenous Plant Flora with medicinal properties including Psilocybin. We believe that the significance of the implications our live plant Extraction Technology can have on not only our yield, but also on an entire industry with its 10-15X Bioavailability has been over looked due to the complexity of the science. In layman’s terms we stand to produce Natural Plant Based Medicine with 10-15 times more bioavailability than current products on the market, at a fraction of the cost. “As we previously discussed, but worth repeating, we entered into this transaction with Protext as we believe there to be numerous synergies by allowing access to certain assets of our established business’ with Protext as well as commercialize the Protext proprietary live plant extraction technology and processes into our existing Genus Cannabis Sativa infrastructure. Prior to the merger, Protext had collaborated with RSAMMD whereby the companies utilized Protext’s proprietary live plant extraction technology along with Kettle extraction equipment to conduct a series of live cannabis extraction testing at New Castle Farm under permits for Genus Cannabis Sativa, with the goal to produce an emulsion rich with cannabinoid but with little to no conversion of THC-A to psychoactive THC. We undertook a series of tests to prove out that the Kettle system and extraction technologies did what they were supposed to do. As part of our previous investigations, various tests were completed using live cannabis flower and leaf, rendered into liquid emulsions supplied by the farm in New Castle. Prior to now, it was hypothecated that processing live Genus Cannabis Sativa under lower temperatures would yield a rich nano-emulsion of phytocannabinoids while retaining the non-psychoactive precursor acid form (THC-A). Our investigations have conclusively demonstrated that full-spectrum cannabinoids can be extracted using the proprietary Kettle system, with minimal metabolic conversion, paving the way for advancement of medical research using non-psychoactive cannabis. What has also intrigued us are the findings from prior research and clinical trials that have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract. This means that our cannabis extract should be more potent while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants. Medically, this opens the door to a line of natural pharmaceuticals derived from cannabis but at a fraction of the price and with potentially superior outcomes. From a business perspective, an increase of bioavailability in that magnitude can be a game changer for cultivators as it essentially could increase the net yield by a factor of 10-15x per plant, per acre, per farm. This initial order is just the beginning and leadership is excited for what’s to come. We will lead the change we want to see in our world” concluded Dr.J. CONTACT INFORMATION For further information, or inquiries relating to partnerships in SA, JV opportunities and/or off-take/supply agreements please feel free to contact us Dylon Du Plooy at: dylon@rsammd.co.za Dr.J at: exportintl@aol.com Follow us at: https://twitter.com/RSAMMD https://twitter.com/ProtextP About Protext (OTC PINK: TXTM) Through its prior acquisitions, Protext has engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. Website: www.protxtm.com About RSAMMDA.LLC: RSAMMDA.LLC. is a wholly owned subsidiary of TXTM focused on acquisitions with two principals, Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”). Mr. Du Plooy is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Dr. J operates the 5000 Hectare New Castle Farm as well as federally issued hemp permits issued by the Government of South Africa. Together, we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabinoids. RSAMMDA.LLC founders are a group of medical doctors and pharmacists, and cannabis activists who have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. We are committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world. Website: www.rsammda.com Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward- looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward- looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation. Contact Details Dylon Du Plooy +27 72 889 2581 dylon@rsammd.co.za Company Website https://www.protxtm.com/

November 01, 2022 02:57 PM Eastern Daylight Time

AmeriLife Welcomes Southern Life Insurance Group to its Growing Distribution Network

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions, announced today that it has partnered with Southern Life Insurance Group. Southern Life Insurance Group, under the leadership of founders and owners Crystal and Nicholas Poe, is an independent marketing organization (IMO) with a legacy of training service-oriented agents and advisors to deliver on the holistic health and financial needs of their clients. Per the agreement, terms of the deal were not disclosed. "Today represents a watershed moment in the history of Southern Life Insurance Group,” said Crystal and Nicholas Poe in a joint statement. “We believe that in order to reach your potential, you should surround yourself with great, trustworthy leaders who hold you accountable and push you to new heights. We’re proud to call many at AmeriLife our friends and mentors, and excited for the future that we’ll build – together – on behalf of our agents and clients." Headquartered in LaGrange, Ga., Southern Life Insurance Group offers competitive life insurance and final expense products as well as annuities, Medicare Advantage and Medicare Supplement solutions, and mortgage protection to beneficiaries across the Southeast as well as in Texas and Michigan. The company has built a strong reputation through its rigorous, four-week development program for new and experienced agents that emphasizes – in equal measures – mentorship, client relationship building, and in-depth product training. Now, with access to AmeriLife’s best-in-class technology, resources and distribution leadership, Southern Life Insurance Group is well positioned to accelerate its nationwide expansion efforts. “I’m pleased to welcome Crystal, Nicholas and the Southern Life Insurance Group family to ours,” said Mike Vietri, AmeriLife’s Chief Distribution Officer. “Their mission, values and approach on training agents, with a holistic perspective on their clients’ needs, is perfectly aligned with AmeriLife’s vision for the future of distribution. Their potential is limitless, and we look forward to helping Southern Life Insurance Group succeed and grow.” ### About Southern Life Insurance Group Southern Life Insurance Group has an unwavering commitment to providing the best personal service possible. We are responsive, offer quality products with solid financial backing by A-rated companies, helpful, friendly associates with extensive knowledge and experience. Our valued clients and their family members can rely on us to be there if and when they need us. We take these obligations very seriously. Everything we do is focused on fulfilling our commitments. As your “agent for life,” we genuinely want you to have the best experience possible every time you deal with Southern Life. For more information, visit SouthernLifeIns.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and more than 100 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

November 01, 2022 01:00 PM Eastern Daylight Time

FORGOTTEN MOM LAUNCHES CAPITAL CAMPAIGN FOCUSING ON MOTHERS WITH ADDICTION, A DRAMATICALLY UNDERSERVED POPULATION

Forgotten Mom Inc.

In an effort to improve outcomes and better support mothers struggling with addiction, a capital campaign for Forgotten Moms is launching today in Florida. According to data collected by the National Institute of Health (NIH), 22M Americans struggle with addiction, 23M are in addiction recovery, and 45M are directly impacted by addiction. Of those checking into treatment centers, 32% are mothers. Additionally, these women need inpatient and outpatient treatment, as well as housing to keep families together and mothers supported. Historically, many women are pushed through the court system on drug charges, where they may end up in jail, separated from their children, with many children going into foster care. Dr. Anita Cocoves, from the Critical Incident Stress Management Team of the Treasure Coast in Florida says, “As we continue to see issues with the opioid epidemic and treatment, women continue to be homeless, without care, and emotionally hopeless. They desperately need treatment, education, and longer-term support to stay healthy.” Farid Dallal, Advisor to NueroPsychiatric Addiction Treatment of Port St. Lucie, Florida, has been underwriting treatment for the last five years with his own money and has spent close to $200,000 providing scholarships for treatment service and access to over 500 people. In 2016, he created the charity, non-profit Forgotten Mom, and is now raising funds to build out a new treatment and housing facility, along with longer-term resource and education supports. Dallal says, “In the past two years, we have lost three non-profits in the South Florida area who have served these women. There is nothing for them. They need a place that is safe, trustworthy, and somewhere to keep their families together. We will be providing longer term educational support as well, to prevent relapse.” The Forgotten Mom Capital Campaign seeks to raise $2.68M and will run through 2023 with a fundraiser and documentary film in development now. They continue to build awareness and services regionally, nationally, and internationally for this necessary treatment. Adriana Cottet, lead coordinator of the capital campaign, adds, “We invite everyone to donate to this critically underserved population. Our goal is to expand our services through this capital campaign and continue to serve more women and their families.” For more information, see www.forgottenmoms.org or info@forgottenmoms.org About Forgotten Mom: Forgotten Mom Inc. (FMI), is a registered (501(c)(3), non-profit initiative established in 2016 to address, support, and find help for the dramatically underserved population of mothers struggling with the disease of addiction. www.forgottenmoms.org Contact Details Farid Dallal +1 646-640-6099 info@forgottenmoms.org Company Website http://www.forgottenmoms.org

November 01, 2022 11:11 AM Eastern Daylight Time

Former Fortune 500 Healthcare Executive Joins AliMed, Inc., As Senior Vice President Of Commercial Growth And Development

AliMed, Inc.

AliMed, Inc., a Massachusetts-based medical supply manufacturer and distributor, announced today that Jeff Hastings has joined its Senior Leadership Team as the Senior Vice President of Commercial Growth and Development. In his new role, Hastings will lead AliMed’s national sales and sales support teams, spearheading commercial expansion of its product portfolio to strengthen the company’s position and market share in both the acute and post-acute care space. Additionally, Hastings will drive efforts to develop and execute programs with preferred suppliers, build on core contract positions within the GPO, federal government, and healthcare-provider segments, and enhance the customer experience. “Jeff has relentlessly proven over his more than 20 years in healthcare leadership to be a key cog in some very critical and highly strategic endeavors,” said Adam S. Epstein, CEO of AliMed. “He is superbly skilled at developing and leading high-performing sales teams with a track record for elevating companies to the next level. We are very excited to welcome Jeff and his talents to our team.” As an influential senior executive in the healthcare industry, Hastings brings decades of leadership experience to AliMed. He has led major corporate initiatives focused on strategic transformation, portfolio diversification, and revenue acceleration for long-term sustainability at some of the nation’s largest healthcare organizations, including Owens and Minor, Cardinal Health, Hill-Rom, Roche Diagnostics, and Vizient (formerly MedAssets). Most recently, Hastings was operating partner at Mountain Pacific Fund, a life sciences investment firm based in Salt Lake City. “AliMed has such a rich, mature, and robust foundation to build on,” Hastings said of AliMed’s more than 50 years in the medical products space. “There is a great sense of enormity in this opportunity, and I’m thrilled—with the support of Adam and a very dedicated AliMed team—to help bring this organization to new heights.” A native of Ohio, Hastings holds a master’s degree in Education from the University of Akron and a bachelor’s degree in Sports Medicine and Health Education from Ashland University. About AliMed AliMed, Inc. manufactures and distributes acute and post-acute medical products and devices. For over 50 years, AliMed has innovated to deliver flexible supply chain solutions with superior service and value-based products focused on the safety and productivity of the healthcare community. AliMed’s broad portfolio of products for domestic and international care providers, dealers, and distributors are designed to improve patient outcomes and experiences from “hospital to home.” Contact Details Amy Fontaine Marketing Communications +1 857-205-8264 afontaine@alimed.com Company Website https://www.alimed.com/

November 01, 2022 10:00 AM Eastern Daylight Time

Image

Black Women, Breast Cancer and the Tests That Can Save Lives

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/13nWSPuDIAs The death rate from breast cancer continues to decline, according to a new report from the American Cancer Society. But there's a wide, worrisome gap in Black women's outcomes that remains unchanged. Black women are more likely to die from breast cancer than white women. While breast cancer incidence rates among Black and white women are close, mortality rates are markedly different, with Black women having a 41% higher death rate from breast cancer. Black women are disproportionally affected by more aggressive breast cancers because of their biology. A recent study showed that Black women are significantly more likely to have genomically High Risk tumors compared to white women, despite having the same clinical factors. This means that, all other things the same – right down to their age and the size of their tumors – the Black women in the study were more likely to have a more aggressive type of cancer. The way we can address some of these disparities is through genomic tests like MammaPrint and BluePrint, which look at 150 important genes within a tumor to estimate the risk of recurrence of that cancer. The number of genes/RNA analyzed by MammaPrint and BluePrint is higher than any other test, and captures the diversity of pathways that allows for consistent results regardless of race and ethnicity. With that information, we as physicians can make more informed decisions with our patients about what their optimal treatment plan should be. There are a few available genomic tests utilized in the clinic to guide discussions around chemotherapy benefit. One example is MammaPrint/BluePrint which are the most comprehensive tests with the most consistent results across diverse groups of patients, compared to other tests. In addition, only the BluePrint test can catch tumor subtypes that may look less dangerous, but actually behave more like triple negative breast cancer when you further classify. This is a very aggressive kind of cancer, that is over-represented among Black women. It is very important the gene expression profiling result a woman receives about her tumor is consistent and reliable regardless of her ethnicity and race, like MammaPrint and BluePrint’s. Studies showing mis-categorization of risk in minority populations due to under-representation of these patients in genomic studies and clinical trials that lead to the approval of these tests is alarming. Every woman with breast cancer has the right to know the correct and clear biological information from her tumor, regardless of her skin color, so she can make timely decisions about her treatment with her care team. For more information about gene expression profiling, including resources that can help you talk to your doctor to make sure the test being offered will work best and most accurately for you, go to Agendia.com. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 01, 2022 10:00 AM Eastern Daylight Time

Video